Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

DexCom, Inc. (DXCM) EV/EBITDA

As of 25 September 2026, DexCom, Inc. (DXCM) trades at a EV/EBITDA of 23.2×. Over the past ten years it has ranged from 0.0× (December 2019) to 860× (November 2018); the current reading is higher than 46% of that period. That is above the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 21.7× (39.59%)
FY2024 36.0× (40.49%)
FY2023 60.4× (25.17%)
FY2022 80.8× (41.99%)
FY2021 139× 50.72%
FY2020 92.4× (9.37%)
FY2019 102× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period EV/EBITDA Change
Jun 2026 17.9× 0.16%
Mar 2026 17.9× (17.54%)
Dec 2025 21.7× (8.90%)
Sep 2025 23.9× (32.61%)
42 more quarters

Against its own ten years

Low 0.0× High 860×
Ten-year median 30.1×
Current reading's percentile 46

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 5.7×
PHG Koninklijke Philips N.V. compare 8.6×
ZBH Zimmer Biomet Holdings, Inc. compare 10.6×
GEHC GE HealthCare Technologies Inc. compare 11.9×
STE STERIS plc compare 13.4×
BSX Boston Scientific Corporation compare 13.8×
DXCM DexCom, Inc. 23.2×
EW Edwards Lifesciences Corporation compare 28.6×
PEN Penumbra, Inc. compare 58.2×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DXCM